Moderna's Melanoma Vaccine Given 'Breakthrough Therapy' Status by FDA - podcast episode cover

Moderna's Melanoma Vaccine Given 'Breakthrough Therapy' Status by FDA

Feb 27, 20233 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Moderna's Melanoma Vaccine has been granted "breakthrough therapy" status by the US Food and Drug Administration (FDA), paving the way for a rapid approval process in just six months. 



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy
For the best experience, listen in Metacast app for iOS or Android